INC Research Holdings, Inc. announced the promotions of Alistair Macdonald and Michael Gibertini, to key roles within the C-suite. Macdonald, who has served as the company's chief operating oficer (COO) since January 2013, has been promoted to president and chief operating officer while Dr. Gibertini, president and general manager, Central Nervous System (CNS) Clinical Development has been appointed to the newly-created role of president, clinical development to lead the Company's therapeutic offerings globally. Prior to assuming the role of COO, Alistair Macdonald was President, Clinical Development Services for INC Research.

Macdonald has more than 20 years of experience in the pharmaceutical industry and has been with INC Research since 2002. He is based in Camberley, United Kingdom. Gibertini joined INC Research in 2005 and since that time has served as president and general manager, CNS Clinical Development providing global leadership for all clinical development programs conducted by the company in the CNS therapeutic area.

Gibertini's experience includes more than 30 years in the pharmaceutical, CRO, academic and private and hospital practice settings and he is considered an expert and leader in CNS clinical trials methodology. In his new role, Gibertini will continue to report directly to CEO Jamie Macdonald.